Genomic Signature Of Colon Cancer May Individualize Treatment
Tuesday, December 2, 2008 - 18:28
in Health & Medicine
Researchers have developed a model for predicting risk of recurrence in early stage colon cancer patients, and have used the model to also predict sensitivity to chemotherapy and targeted therapy regimens.